Efficacy and Safety of Trabectedin or Dacarbazine for the Treatment of Patients With Uterine Leiomyosarcoma After Prior Chemotherapy: A Subgroup Analysis of the Randomized Phase 3 SAR-3007 Study
Gynecologic Oncology - United States
doi 10.1016/j.ygyno.2016.04.035
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2016
Authors
Publisher
Elsevier BV